·
4 Min Read

AMA urges federal action to respond to insulin price hikes

With insulin prices spiking, the AMA urged the FTC and Justice Department to monitor insulin pricing and market competition.

Press Releases
·
3 Min Read

AMA: Drug shortages a matter of national security

Hurricane Maria wreaked further havoc in pharmaceutical production and has contributed to an urgent public health crisis, says the AMA House of Delegates.

Behavioral Health
·
3 Min Read

New AMA policy reflects frustration over ongoing drug shortages

Responding to ongoing national drug shortages that threaten patient care, AMA adopted policy declaring drug shortages an urgent public health crisis.

Press Releases
·
7 Min Read

May 31, 2018: National Advocacy Update

Trump administration plan to lower drug prices, compounding from bulk substances and more in the latest AMA national health care advocacy news.

Advocacy Update
·
2 Min Read

May 17, 2018: Advocacy spotlight on Trump Administration releases drug pricing blueprint

Trump Administration releases drug pricing blueprint; AMA and Federation members are looking into impact on specialty treatments and other concerns.

Advocacy Update
·
1 Min Read

AMA President Barbe applauds Trump effort on prescription drug prices

The AMA is pleased the Trump administration is moving forward with its effort to address seemingly arbitrary pricing for prescription drugs.

Press Releases
7 Min Read

AMA model bills

View the most frequently used model state bills created for the Federation of Medicine and approved by the AMA Board of Trustees.

State Advocacy
·
6 Min Read

April 5, 2018: National Advocacy Update

Controlled substance e-prescribing, new alternative payment models and more in the latest AMA national health care advocacy news.

Advocacy Update
Commentors standing in line at microphone to make a remark.
·
2 Min Read

Physicians aim to shine light on why drugs cost so much

The AMA will seek to ban unjustified prescription-drug “price gouging” and let pharmacists tell patients when their co-pay exceeds a drug’s cash price.

Behavioral Health